The expansion of Raleigh as a hub for innovation and technology continues to soar. As of March 2025, Raleigh ranks second in ...

GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

RTP is a word that is thrown about a lot in the world of online gaming. In slots especially, RTP percentages are usually displayed and these can range in the mid to high 90s. Some players may ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Several hundred people work in this division at the EPA’s campus at Research Triangle Park. Scientists here have conducted research for decades to inform environmental policies. "They love the ...

Several hundred people work in this division at the EPA’s campus at Research Triangle Park. Scientists here have conducted research for decades to inform environmental policies. "They love the impact ...

Shortly after President Donald Trump won his second presidential election in the U.S. last fall, British drugmaker GSK came to federal prosecutors in New York, bearing intel from employees ...

GSK plc announced a major new research collaboration with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to advance understanding of neurodegeneration with a first-of ...

Could the U.S. Environmental Protection Agency consolidate workers into Research Triangle Park or close the campus altogether? STORY HIGHLIGHTS Could the U.S. Environmental Protection Agency ...

GSK is studying a group of more than a million older adults in the UK to see if its shingles vaccine lowers the risk of dementia. The British drugs group, led by boss Emma Walmsley, is using the ...

GSK said last year the antibiotic succeeded in a late-stage trial and plans to seek approval in that indication as well. GSK scientists discovered the drug, which was developed in part through the ...

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of oral antibiotics for the condition in nearly 30 years. Blujepa, also ...